NFIB and glioblastoma: In contrast, the lower level of NFIB in classical and mesenchymal GBM may be due to genetic/epigenetic changes that reduce NFIB expression in these two subtypes, resulting in their poorly-differentiated phenotype yet leaving them sensitive to the effects of re-expressed NFIB.